11-111549734-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_178834.5(LAYN):c.500G>A(p.Arg167Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000117 in 1,453,236 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 33)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
LAYN
NM_178834.5 missense
NM_178834.5 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.49
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.27851284).
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000247 AC: 6AN: 242478Hom.: 0 AF XY: 0.00000763 AC XY: 1AN XY: 131130
GnomAD3 exomes
AF:
AC:
6
AN:
242478
Hom.:
AF XY:
AC XY:
1
AN XY:
131130
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000117 AC: 17AN: 1453236Hom.: 0 Cov.: 33 AF XY: 0.0000111 AC XY: 8AN XY: 722544
GnomAD4 exome
AF:
AC:
17
AN:
1453236
Hom.:
Cov.:
33
AF XY:
AC XY:
8
AN XY:
722544
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.500G>A (p.R167Q) alteration is located in exon 3 (coding exon 3) of the LAYN gene. This alteration results from a G to A substitution at nucleotide position 500, causing the arginine (R) at amino acid position 167 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;.;.;.
PrimateAI
Benign
T
PROVEAN
Uncertain
D;N;N;N;N;D
REVEL
Benign
Sift
Benign
T;D;D;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
0.39, 0.80, 0.72
.;B;P;P;P;.
Vest4
0.16, 0.17, 0.17, 0.24
MutPred
0.48
.;.;Gain of ubiquitination at K179 (P = 0.1047);Gain of ubiquitination at K179 (P = 0.1047);.;.;
MVP
MPC
0.25
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at